EDUCATION AND TRAINING

M.D., University of California School of Medicine, Davis, 1989

Internship and Residency in Internal Medicine, University of Washington, 1989-1992

Chief Resident, VA Medical Center, Seattle, Washington, 1992-1993

Endocrinology Fellow, University of Washington, 1993-1995

  Bradley D. Anawalt, M.D.
Associate Professor of Medicine
Staff Physician, General Internal Medicine and
     Endocrinology, VA Puget Sound Health Care System
Assistant Care Line Manager, Primary and Specialty
     Care of VA Puget Sound

Division of General Internal Medicine


OFFICE ADDRESS

VA Puget Sound Health Care System 
1660 South Columbian Way
Campus Box 358280 (111M)
Seattle, WA 98108

Email: Bradley.Anawalt@med.va.gov
Academic Office: (206) 764-2345
Fax: (206) 764-2903


HONORS

Paul Beeson Award for excellence in teaching, 1999
Endocrine Society Travel Award, 1999
Endocrine Society Travel Award, 1997
Merck Award for outstanding scholarship, 1989
Alpha Omega Alpha, 1988


CURRENT RESEARCH INTERESTS

Male contraception
Male reproduction
Male hypogonadism
Male reproductive physiology
Effects of androgens on bone, muscle and cognition


REPRESENTATIVE PUBLICATIONS

 Herbst KL, Anawalt BD, Amory JK, Matsumoto AM, Bremner WJ.  The male contraceptive regimen of testosterone and levonorgestrel significantly increases lean mass in healthy young men in 4 weeks, but attenuates a decrease in fat mass induced by testosterone alone.J Clin Endocrinol Metab. 88(3):1167-73, 2003.

Grant NN and Anawalt BD.  Androgens in primary care.  Primary Care Clinics of North America, 30:743-764, 2003.

McLachlan RI, Robertson DM, Pruysers E, Ugoni A, Matsumoto AM, Anawalt BD, Bremner WJ, Meriggiola CM.  Relationship between serum gonadotropins and spermatogenic suppression in men undergoing steroidal contraceptive treatment.  J Clin Endocrinol Metab, 89:142-149, 2004.

Amory JK, Watts NB, Easley KA, Sutton PR, Anawalt, BD, Matsumoto AM, Bremner WJ, Tenover L.  Testosterone with Finasteride for Bone Mineral Density and Prostate Health in Older Men. J Clin Endocrinol Metab, 2004;89:503-510.

Herbst KL, Coviello AD, Page S, Amory JK, Anawalt BD, Bremner WJ.  A single dose of the potent gonadotropin releasing-hormone antagonist acyline suppresses gonadotropins and testosterone for 2 weeks in healthy young men.  J Clin Endocrinol Metab, in press.





GIM Home | UW Home | SoM Home | DoM Home
Academic Medical Centers | Academic HealthLinks


Please honor our copyrights and disclaimer.
Copyright
©1998 University of Washington. All rights reserved.
Comments to General Internal Medicine, gim@u.washington.edu
Last reviewed: July 25, 2007 - Last updated: July 25, 2007 (mb)